NGL Fine Chem Ltd (NGLFINE) Share Price & Fundamentals

What we do

NGL Fine Chem Ltd is a pharmaceutical company specializing in manufacturing APIs and intermediates for veterinary and human health sectors.

Founded in

1,981

Market share

Market leader in veterinary APIs with 15% to over 50% share in key products globally.

Problem solved

Provides critical raw materials and APIs addressing quality and cost competitiveness in pharmaceutical manufacturing.

Top clients or who we serve

Suppliers to top global animal healthcare companies; serves B2B pharmaceutical and veterinary industries globally.

Key management

Rahul Nachane, Managing Director; Rajesh Lawande, Whole-Time Director & CFO; both with extensive industry expertise.

Our journey and innovations

Incorporated in 1981; expanded manufacturing capacities; acquired Macrotech Polychem; ongoing greenfield expansion at Tarapur.

Where we operate

India, Europe, Asia Pacific, USA, and other international markets with regulatory approvals in controlled markets.

Top products or what we offer

40 APIs including 38 veterinary, 2 human APIs, intermediates, and formulations; focus on veterinary health segment.

Top brands

-

Raw materials needed

Chemical substances for pharmaceutical and allopathic medicine production.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue is primarily recurring based on long-term supply contracts and customer relationships.

Our industry position

Strong standing in veterinary APIs, backed by high manufacturing integration and stringent quality standards.

Financial highlights

Revenue of ₹368 crore and net profit of ₹21 crore for FY25; 9.22% revenue growth over prior year.

Geographical revenue split

Revenue spread across India, Europe, Asia Pacific, USA, and Rest of World.

Order book

-

Whats driving growth

Volume growth, operational efficiencies, regulatory approvals, and ongoing capacity expansions.

Our future plans

Greenfield expansion at Tarapur to complete by Jan 2026 with investments ~₹210 crore, enhancing manufacturing scale.

Our green promise

Zero liquid discharge facilities covering 75% production; ISO 14001 certified for environmental management.

Our people and values

Committed to ethical standards and high governance; zero tolerance for workplace harassment; ongoing employee programs.

Key challenges ahead

Pricing pressures, regulatory environment changes, and supply chain risks.

Interesting facts

SME 1 credit rating and multiple global regulatory approvals for APIs.

Risks and strategy

Addressing pricing and regulatory risks via diversification, efficiency improvements, and expanding product portfolio.